Guidelines for management of hypothyroidism

Monitoring hypothyroidism—and avoiding complications Testing guidelines for the management of hypothyroidism1 Patients with overt hypothyroidism on levothyroxine therapy TSH measurements: • 4-8 weeks following initiation of therapy or after a change in dose • 6 months after initial treatment • Every 12 months thereafter, or more

lines for the diagnosis and management of patients with hyperthyroidism have been published previously by both the American Thyroid Association (ATA) and American Association of Clinical Endocrinologists (AACE), in con-junction with guidelines for the treatment of hypothyroid-ism (1,2), both associations determined that thyrotoxicosis New paradigms since publication of the 2011 guidelines are presented for the evaluation of the etiology of thyrotoxicosis, the management of Graves' hyperthyroidism with antithyroid drugs, the management of pregnant hyperthyroid patients, and the preparation of patients for thyroid surgery. The Hypothyroidism GUIDELINES Pocket Guide is endorsed by The American Thyroid Association and based on their latest guidelines. It contains detailed, graded recommendations for treating hypothyroidism in adults, children and during pregnancy, including hospitalized patients and myxedema coma. Updated evidence-based recommendations from the American Thyroid Association (ATA) provide guidance on how best to diagnose and manage thyroid dysfunction during pregnancy, especially mild or "subclinical" hypothyroidism. 1 The guidelines offer specific treatment recommendations for various levels of thyroid dysfunction and targets for therapy. The recommendations on management of subclinical or overt hypothyroidism in the postpartum period are based on the clinical guidelines UK guidelines for the use of TFTs [Association for Clinical Biochemisty, 2006], Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum DIETARY RECOMMENDATIONS TO HYPOTHYROI